Notably, periplocin, a bioactive compound derived from Periploca sepium, suppresses MDSC accumulation in HCC tumors by blocking the AKT/NF-κB pathway, thereby inhibiting CXCL1/CXCL3-mediated chemotaxis [114]. This evidence concerns the gene CXCL1 and hepatocellular carcinoma.